Nonetheless, given the ubiquitous presence of fibroblasts in cancer and the avidity of FAP-targeted imaging agents, FAP-targeted PET imaging has the potential to revolutionize the landscape of oncological PET/CT imaging and improve the clinical care of this highly problematic disease. This evidence concerns the gene FAP and cancer.